STOCK TITAN

Zhibao Technology (ZBAO) replaces CFO and adds three new independent directors

(Neutral)
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Zhibao Technology Inc. reported significant leadership and board changes. On July 1, 2026, director and Chief Financial Officer Yuanwen Xia and three independent directors resigned, and the board stated these departures were not due to any disagreement over operations, policies, or practices.

The board appointed Guangtong Ren, previously Chief Actuary, as both director and Chief Financial Officer, highlighting his more than 25 years of experience in corporate finance, insurance, and risk management. New independent directors Jun Ma, YiYun Dai, and Han Tang were also appointed and assigned leadership roles across the Audit, Compensation, and Nominating and Corporate Governance Committees.

Positive

  • None.

Negative

  • None.

Insights

Multiple directors and the CFO were replaced, but the company reports no underlying disputes.

Zhibao Technology Inc. disclosed a coordinated refresh of its board and finance leadership. The prior CFO and three independent directors resigned effective July 1, 2026, and the company explicitly stated these exits were not linked to disagreements on operations, policies, or practices.

The board simultaneously appointed Guangtong Ren, its Chief Actuary since December 2025, as CFO and director, emphasizing his long experience in insurance, risk and finance. Three new independent directors were added and immediately placed in key roles on the Audit, Compensation, and Nominating and Corporate Governance Committees, helping maintain required committee structures.

For investors, this represents a notable governance transition rather than a quantified financial event. The filing focuses on backgrounds and committee assignments; future company disclosures may clarify how the new leadership influences strategy, financial oversight, and risk management.

Effective date of resignations and appointments July 1, 2026 Date when CFO and directors resigned and successors were appointed
Experience of new CFO Over 25 years Corporate finance, strategic planning, and risk management experience of Guangtong Ren
Start of Ren’s Chief Actuary role December 2025 Date Guangtong Ren became Chief Actuary of the company
Start of Ren’s role at Zhibao Technology Co., Ltd. November 2023 Executive Director and Chief Actuary of Zhibao Technology Co., Ltd.
Start of Ren’s role at Zhibao Labuan Re April 2025 Principal Insurance Officer of Zhibao Labuan Re Co., Ltd.
independent director financial
"Armando Luis Baez, Stephen Bernardez, and Jeffery Rong Cai each resigned from his position as an independent director of the Company"
An independent director is a member of a company's board of directors who is not involved in the company's day-to-day operations and has no significant relationships with the company that could influence their judgment. Their role is to provide unbiased oversight and ensure the company is managed in the best interests of all shareholders. This helps build trust and confidence among investors by promoting transparency and accountability.
Audit Committee financial
"YiYun Dai as the chair person and a member of the Audit Committee, and a member of each of the Compensation Committee and Nominating and Corporate Governance Committee"
A company's audit committee is a small group of board members who act like independent inspectors for the firm's finances, overseeing how financial reports are prepared, monitoring internal controls, and managing the relationship with external auditors. Investors care because a strong audit committee reduces the risk of accounting errors, fraud, or misleading statements, making financial statements more trustworthy and helping protect shareholder value.
Compensation Committee financial
"Han Tang as the chair person and a member of the Compensation Committee, and a member of each of the Audit Committee and Nominating and Corporate Governance Committee"
A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.
Nominating and Corporate Governance Committee financial
"Jun Ma as the chair person and a member of the Nominating and Corporate Governance Committee, and a member of each of the Compensation Committee and Audit Committee"
A nominating and corporate governance committee is a group within a company's board of directors responsible for selecting and recommending individuals to serve as company leaders, such as directors or executives. They also develop and oversee policies to ensure the company is run fairly, ethically, and transparently. This committee matters to investors because it helps ensure the company is well-managed and guided by qualified, responsible leadership.
foreign private issuer regulatory
"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
Chief Actuary financial
"the Board appointed Guangtong Ren, the Company’s current Chief Actuary, as a director and Chief Financial Officer of the Company"
A chief actuary is the senior executive who leads the team that uses math and statistics to estimate future costs, risks, insurance claims and pension obligations. They set pricing, reserves and assumptions that affect a company’s reported profits and solvency, so investors watch them much like a ship’s chief engineer—responsible for keeping the business on course financially and avoiding costly surprises.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What leadership changes did Zhibao Technology Inc. (ZBAO) report on July 1, 2026?

Zhibao Technology Inc. reported that director and Chief Financial Officer Yuanwen Xia and three independent directors resigned effective July 1, 2026. The board simultaneously appointed Guangtong Ren as director and CFO and added three new independent directors.

Who is the new Chief Financial Officer of Zhibao Technology Inc. (ZBAO)?

The new Chief Financial Officer is Guangtong Ren, formerly the company’s Chief Actuary. He has over 25 years of experience in corporate finance, strategic planning, and risk management across insurance, investment management, and start-up environments.

Did the resignations at Zhibao Technology Inc. (ZBAO) involve disagreements with the company?

The company stated that each resignation, including that of CFO and director Yuanwen Xia and three independent directors, was not due to any disagreement with Zhibao Technology Inc. on operations, policies, or practices.

Which new independent directors joined the Zhibao Technology Inc. (ZBAO) board?

The board appointed Jun Ma, YiYun Dai, and Han Tang as independent directors effective July 1, 2026. Their backgrounds span healthcare management, insurance and consulting, marketing, and business operations across several industries.

How were board committee roles reallocated at Zhibao Technology Inc. (ZBAO)?

The new independent directors assumed key committee roles. Jun Ma, YiYun Dai, and Han Tang were appointed as chairs or members of the Audit, Compensation, and Nominating and Corporate Governance Committees, ensuring these governance bodies remain fully staffed.

What relevant experience does Zhibao’s new CFO, Guangtong Ren, bring to the role?

Guangtong Ren has served as Chief Actuary of the company since December 2025 and holds over 25 years of experience in corporate finance, insurance, and risk management, including senior roles at AIG Insurance China and other financial institutions.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of July 2026

 

Commission File Number: 001-42000

 

Zhibao Technology Inc.

(Translation of registrant’s name into English)

 

Floor 3, Building 6, Wuxing Road, Lane 727

Pudong New Area, Shanghai, China, 201204

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F             Form 40-F

 

 

 

 

 

 

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

 

Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers

 

On July 1, 2026, Yuanwen Xia resigned from his positions as a director and Chief Financial Officer of Zhibao Technology Inc., a Cayman Islands exempted company (the “Company”), and Armando Luis Baez, Stephen Bernardez, and Jeffery Rong Cai each resigned from his position as an independent director of the Company (collectively, the “Resignations”). The board of directors of the Company (the “Board”) accepted the Resignations, each effective as of July 1, 2026. Each of the Resignations was not due to any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.

 

On the same date, the Board appointed Guangtong Ren, the Company’s current Chief Actuary, as a director and Chief Financial Officer of the Company, and appointed Jun Ma, YiYun Dai, and Han Tang as independent directors of the Company, effective July 1, 2026. In addition, the Board also appointed (i) Jun Ma as the chair person and a member of the Nominating and Corporate Governance Committee, and a member of each of the Compensation Committee and Audit Committee, (ii) YiYun Dai as the chair person and a member of the Audit Committee, and a member of each of the Compensation Committee and Nominating and Corporate Governance Committee, and (iii) Han Tang as the chair person and a member of the Compensation Committee, and a member of each of the Audit Committee and Nominating and Corporate Governance Committee, effective as of July 1, 2026. 

 

Mr. Guangtong Ren has served as Chief Actuary of the Company since December 2025. Mr. Ren has over 25 years of extensive experience in corporate finance, strategic planning, and risk management of insurance, investment management and start-ups. Mr. Ren has served as Executive Director and Chief Actuary of Zhibao Technology Co., Ltd. since November 2023, and Principal Insurance Officer of Zhibao Labuan Re Co., Ltd., a subsidiary of the Company, since April 2025. From August 2020 to November 2023, Mr. Ren served as special advisor to Chief Executive Officer at GLP Capital Partners Limited, a global leader in providing industrial services and investment focused on next-generation infrastructure in the supply chain, big data, and new energy sectors. From August 2018 to July 2020, Mr. Ren served as an advisor to the Chairman at Lupu Investment Holding Group Ltd., a Group specializing in wealth management and private equity investment. From October 2006 to June 2018, Mr. Ren served as Chief Financial Officer, Regional Finance Actuary and Greater China Chief Risk Officer of AIG Insurance Company China Limited, an international insurance organization serving commercial, institutional and individual customers. From August 2004 to January 2006, Mr. Ren served as Consultant of the Boston Consulting Group, a global management consulting firm. From July 1994 to July 2004, Mr. Ren served as Deputy General Manager of Ping An Insurance (Group) Company of China, Ltd., a Chinese financial services holding company whose subsidiaries provide insurance, banking, asset management, and financial services. Mr. Ren received his Master of Business Administration degree in Finance from London Business School in 2004, a master’s degree in Finance/Actuarial Science from Nankai University in 1994, and a bachelor’s degree in Mathematical Statistics from Nankai University in 1991. We believe Mr. Ren’s years of experience in corporate finance, insurance and investment management, together with his familiarity with the Company’s business and operations, qualifies him to serve on our board of directors.

 

Mr. Jun Ma has extensive experience in healthcare management. In 2003, Mr. Ma established an organ transplant intensive care unit, or ICU, in China at Shanghai Changzheng Hospital, where he served as Director and Professor until December 2023. Since November 2024, Mr. Ma has served as General Manager of Fanyi Health Corp., a healthcare company established in the United States. Mr. Ma received a bachelor’s degree in Clinical Medicine from Naval Medical University in Shanghai, and a master’s degree in Emergency and Critical Care Medicine from Shanghai Changzheng Hospital ICU. We believe Mr. Ma’s extensive experience in healthcare management qualifies him to serve on our board of directors.

 

Ms. YiYun Dai has extensive experience in the insurance and consulting sectors. From March 2020 to August 2024, Ms. Dai served as a consultant at Global Benefits Group China, where she advised on business development, operational infrastructure, and reinsurance partnerships. From July 2016 to February 2020, Ms. Dai served as Chief Executive Officer of Global Benefits Group China, where she led a comprehensive organizational restructuring of the Greater China business. From July 2015 to June 2016, Ms. Dai served as Assistant General Manager at Alltrust Insurance Co., Ltd., where she partnered with overseas insurers to launch accident and health and high-end medical insurance products in China, and led several cross-border initiatives. Prior to that, from April 2007 to December 2010, Ms. Dai served as Accident & Health Manager at Chubb Insurance China Company Limited, where she managed underwriting performance and product development. Ms. Dai received a Master of Business Administration degree from Columbia International Institute in collaboration with Beijing University, and a bachelor’s degree in Japanese from the Shanghai Institute of Tourism. We believe Ms. Dai’s extensive experience in insurance operations and business development qualifies her to serve on our board of directors.

 

Ms. Han Tang has extensive experience in marketing and business operations across multiple industries, including consumer products and insurance. From 2019 to 2021, Ms. Tang served as Marketing and Operation Director at Shanghai Curly Baby Trading Co., Ltd., where she was responsible for overseeing the company’s overall operations and marketing promotion in the baby and children’s food and products sector. From 2015 to 2017, Ms. Tang served as Marketing Director at Shanghai Anyi Tech Co., Ltd., an insurance brokerage and risk management company, where she was responsible for developing and executing marketing strategies. Prior to that, from 2010 to 2015, Ms. Tang served as Senior Marketing Manager at Willis Towers Watson (NASDAQ: WTW), where she managed sales and marketing functions within the insurance brokerage and risk advisory business. In addition, from 2008 to 2010, Ms. Tang served as Executive Assistant to the General Manager of ADP China (NASDAQ: ADP), where she was responsible for managing executive-level business scheduling, communications, and administrative support in the payroll and human resources services sector. Ms. Tang received a master’s degree in Business Administration from Renmin University of China, and a bachelor’s degree in Administrative Management from Donghua University in Shanghai, China. We believe Ms. Tang’s extensive experience in marketing strategy, operations management, and the insurance and consumer products industries qualifies her to serve on our board of directors.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Zhibao Technology Inc.
   
  By: /s/ Botao Ma
  Name:   Botao Ma
  Title: Chief Executive Officer

 

 

Date: July 6, 2026

 

 

2